Compressive properties and degradability of poly(epsilon-caprolatone)/hydroxyapatite composites under accelerated hydrolytic degradation.

Hydroxyapatite (HA) was incorporated as filler into polycaprolactone (PCL) matrix to improve the bioactivity as well as the compressive properties of the polymer composites that can be typically used in tissue engineering scaffolds. The compressive properties of five PCL/HA composites of different compositions were investigated in conjunction with the study of their rate of degradation. As PCL has a slow degradation rate, the experiment was conducted in a concentrated 5M sodium hydroxide medium to accelerate the degradation process. The compressive strength and modulus of all PCL/HA compositions were observed to decrease as the degradation experiment progressed, with samples having high HA content degraded most significantly as compared with samples with lower HA content. Pure PCL samples, however, were found to retain their mechanical properties comparatively well in the same degradation experiments. Although the addition of HA as filler into the PCL matrix was shown to have improved mechanical properties and bioactivity initially, these results do raise concerns of material properties being compromise during hydrolytic degradation.

[1]  S. Monroe,et al.  Clinical evaluation of the Capronor contraceptive implant: preliminary report. , 1989, American journal of obstetrics and gynecology.

[2]  Robert Langer,et al.  Modeling of Polymer Erosion , 1993 .

[3]  S A Goldstein,et al.  The relationship between the structural and orthogonal compressive properties of trabecular bone. , 1994, Journal of biomechanics.

[4]  Toshio Hayashi,et al.  BIODEGRADABLE POLYMERS FOR BIOMEDICAL USES , 1994 .

[5]  A. Göpferich,et al.  Polymer Bulk Erosion , 1997 .

[6]  Antonios G. Mikos,et al.  Fabrication of Biodegradable Polymer Scaffolds for Tissue Engineering , 1998 .

[7]  L. Weiss,et al.  In vitro analysis of biodegradable polymer blend/hydroxyapatite composites for bone tissue engineering. , 1999, Journal of biomedical materials research.

[8]  G. Eastmond Poly(ε-caprolactone) Blends , 2000 .

[9]  D. Hutmacher,et al.  Scaffolds in tissue engineering bone and cartilage. , 2000, Biomaterials.

[10]  P. Kumta,et al.  Characterization of osteoblast-like behavior of cultured bone marrow stromal cells on various polymer surfaces. , 2000, Journal of biomedical materials research.

[11]  M. Textor,et al.  Biodegradable polymer/hydroxyapatite composites: surface analysis and initial attachment of human osteoblasts. , 2001, Journal of biomedical materials research.

[12]  A. Göpferich,et al.  Why degradable polymers undergo surface erosion or bulk erosion. , 2002, Biomaterials.

[13]  Changyou Gao,et al.  Surface modification of polycaprolactone with poly(methacrylic acid) and gelatin covalent immobilization for promoting its cytocompatibility. , 2002, Biomaterials.

[14]  N. Washburn,et al.  Structure and mechanical properties of poly(?,?-lactic acid)/poly(ɛ-caprolactone) blends , 2003 .

[15]  Toshihiro Akaike,et al.  A novel degradable polycaprolactone networks for tissue engineering. , 2003, Biomaterials.

[16]  J. Vacanti,et al.  A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. , 2003, Biomaterials.

[17]  L. Ambrosio,et al.  Osteoblast growth and function in porous poly epsilon -caprolactone matrices for bone repair: a preliminary study. , 2003, Biomaterials.

[18]  M. B. Claase,et al.  Development and properties of polycaprolactone/hydroxyapatite composite biomaterials , 2003, Journal of materials science. Materials in medicine.

[19]  S. Rhee Bone-like apatite-forming ability and mechanical properties of poly(ε-caprolactone)/silica hybrid as a function of poly(ε-caprolactone) content , 2004 .